129 related articles for article (PubMed ID: 8564107)
1. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema.
Llewellyn-Jones CG; Harris TA; Stockley RA
Am J Respir Crit Care Med; 1996 Feb; 153(2):616-21. PubMed ID: 8564107
[TBL] [Abstract][Full Text] [Related]
2. Effect of fluticasone propionate on neutrophil chemotaxis, superoxide generation, and extracellular proteolytic activity in vitro.
Llewellyn-Jones CG; Hill SL; Stockley RA
Thorax; 1994 Mar; 49(3):207-12. PubMed ID: 8202875
[TBL] [Abstract][Full Text] [Related]
3. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease.
Culpitt SV; Maziak W; Loukidis S; Nightingale JA; Matthews JL; Barnes PJ
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1635-9. PubMed ID: 10556133
[TBL] [Abstract][Full Text] [Related]
4. In vivo study of indomethacin in bronchiectasis: effect on neutrophil function and lung secretion.
Llewellyn-Jones CG; Johnson MM; Mitchell JL; Pye A; Okafor VC; Hill SL; Stockley RA
Eur Respir J; 1995 Sep; 8(9):1479-87. PubMed ID: 8575572
[TBL] [Abstract][Full Text] [Related]
5. In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation.
Loppow D; Schleiss MB; Kanniess F; Taube C; Jörres RA; Magnussen H
Respir Med; 2001 Feb; 95(2):115-21. PubMed ID: 11217907
[TBL] [Abstract][Full Text] [Related]
6. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.
Barnes NC; Qiu YS; Pavord ID; Parker D; Davis PA; Zhu J; Johnson M; Thomson NC; Jeffery PK;
Am J Respir Crit Care Med; 2006 Apr; 173(7):736-43. PubMed ID: 16424444
[TBL] [Abstract][Full Text] [Related]
7. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis.
Tsang KW; Ho PL; Lam WK; Ip MS; Chan KN; Ho CS; Ooi CC; Yuen KY
Am J Respir Crit Care Med; 1998 Sep; 158(3):723-7. PubMed ID: 9730996
[TBL] [Abstract][Full Text] [Related]
8. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.
Hattotuwa KL; Gizycki MJ; Ansari TW; Jeffery PK; Barnes NC
Am J Respir Crit Care Med; 2002 Jun; 165(12):1592-6. PubMed ID: 12070058
[TBL] [Abstract][Full Text] [Related]
9. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study.
Olivieri D; Chetta A; Del Donno M; Bertorelli G; Casalini A; Pesci A; Testi R; Foresi A
Am J Respir Crit Care Med; 1997 Jun; 155(6):1864-71. PubMed ID: 9196087
[TBL] [Abstract][Full Text] [Related]
10. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
[TBL] [Abstract][Full Text] [Related]
11. Effects of pentoxifylline on sputum neutrophil elastase and pulmonary function in patients with cystic fibrosis: preliminary observations.
Aronoff SC; Quinn FJ; Carpenter LS; Novick WJ
J Pediatr; 1994 Dec; 125(6 Pt 1):992-7. PubMed ID: 7996376
[TBL] [Abstract][Full Text] [Related]
12. Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial.
Bourbeau J; Christodoulopoulos P; Maltais F; Yamauchi Y; Olivenstein R; Hamid Q
Thorax; 2007 Nov; 62(11):938-43. PubMed ID: 17557771
[TBL] [Abstract][Full Text] [Related]
13. Inhaled corticosteroids may reduce neutrophilic inflammation in patients with stable chronic obstructive pulmonary disease.
Yildiz F; Kaur AC; Ilgazli A; Celikoglu M; Kaçar Ozkara S; Paksoy N; Ozkarakaş O
Respiration; 2000; 67(1):71-6. PubMed ID: 10705266
[TBL] [Abstract][Full Text] [Related]
14. Proteinase/proteinase inhibitor imbalance in sputum sol phases from patients with chronic obstructive pulmonary disease. Suggestions for a key role played by antileukoprotease.
Piccioni PD; Kramps JA; Rudolphus A; Bulgheroni A; Luisetti M
Chest; 1992 Nov; 102(5):1470-6. PubMed ID: 1385052
[TBL] [Abstract][Full Text] [Related]
15. Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics.
Kawayama T; Kinoshita T; Imaoka H; Gauvreau GM; O'Byrne PM; Aizawa H
Respirology; 2008 Nov; 13(7):1000-1007. PubMed ID: 18699801
[TBL] [Abstract][Full Text] [Related]
16. Eosinophilic bronchitis in asthma: a model for establishing dose-response and relative potency of inhaled corticosteroids.
Kelly MM; Leigh R; Jayaram L; Goldsmith CH; Parameswaran K; Hargreave FE
J Allergy Clin Immunol; 2006 May; 117(5):989-94. PubMed ID: 16675323
[TBL] [Abstract][Full Text] [Related]
17. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related.
Reid DW; Wen Y; Johns DP; Williams TJ; Ward C; Walters EH
Respirology; 2008 Nov; 13(6):799-809. PubMed ID: 18811878
[TBL] [Abstract][Full Text] [Related]
18. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
[TBL] [Abstract][Full Text] [Related]
19. Effect of inhaled fluticasone propionate on BAL TGF-beta(1) and bFGF concentrations in clinically stable lung transplant recipients.
Zheng L; Walters EH; Wang N; Whitford H; Orsida B; Levvey B; Bailey M; Williams TJ; Snell GI
J Heart Lung Transplant; 2004 Apr; 23(4):446-55. PubMed ID: 15063404
[TBL] [Abstract][Full Text] [Related]
20. The chemotactic activity of sputum from patients with bronchiectasis.
Mikami M; Llewellyn-Jones CG; Bayley D; Hill SL; Stockley RA
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):723-8. PubMed ID: 9517582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
